Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCCResectable Hepatocellular CarcinomaRecruitingPhase 22026-07-08NCT07018947

1 results · Page 1 of 1

Swipe the table sideways for more columns.

12 results · Page 1 of 1